Alexander M Klibanov

USPTO Granted Patents = 39 (Patent Applications = 17)

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 3.3

ph-index = 16

Forward Citations = 1,289(Granted Patents)

Location History:

Newton, MA (US) (1989 - 2015)
Boston, MA (US) (1983 - 2024)

Company Filing History:

11 out of 8,373

Massachusetts Institute of Technology

patents

11 out of 11

Eagle Biologics, Inc.

patents

9 out of 28

Collegium Pharmaceutical, Inc.

patents

4. 4 out of 14

Cambridge Scientific, Inc.

University of Pennsylvania

patents

7. 1 out of 11

Capitol Specialty Plastics, Inc.

where one patent can have more than one assignee

Years Active: 1983-2024

Loading Chart...

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11986526 - Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC) (2024-05-21),

2. 11819550 - Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP) (2023-11-21),

3. 11471479 - Polysaccharide and nucleic acid formulations containing viscosity-lowering agents (2022-10-18),

4. 10849977 - Liquid Protein Formulations Containing Thiamine (2020-12-01),

5. 10821184 - Liquid protein formulations containing thiamine pyrophosphate (TPP) (2020-11-03),

6. 10821183 - Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM) (2020-11-03),

7. 10646571 - Liquid protein formulations containing cimetidine (2020-05-12),

8. 10525053 - Abuse-deterrent pharmaceutical compositions of opioids and other drugs (2020-01-07),

9. 10525052 - Abuse-deterrent drug formulations (2020-01-07),

10. 10500317 - Antibacterial coatings that inhibit biofilm formation on implants (2019-12-10),

11. 10179172 - Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof (2019-01-15),

12. 9925263 - Liquid pharmaceutical formulations for injection comprising procaine and uses thereof (2018-03-27),

13. 9913905 - Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof (2018-03-13),

14. 9833513 - Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof (2017-12-05),

15. 9763883 - Abuse-deterrent drug formulations (2017-09-19),

Title: The Innovative Journey of Alexander M Klibanov

Introduction:

Alexander M Klibanov is a renowned inventor based in Boston, MA. He has made significant contributions to the field of innovations and patents, particularly in the realm of biotechnology and medical devices.

Latest Patents:

Alexander M Klibanov holds several patents in the areas of drug delivery systems, medical imaging technologies, and biomaterials. His recent patents showcase his commitment to advancing healthcare through innovative solutions.

Career Highlights:

With a background in bioengineering and pharmaceutical sciences, Alexander M Klibanov has had a distinguished career marked by groundbreaking inventions. His work has not only revolutionized the medical industry but has also improved the quality of life for many individuals.

Collaborations:

Throughout his career, Alexander M Klibanov has collaborated with leading researchers, scientists, and medical professionals to bring his inventions to life. His collaborative efforts have led to the development of cutting-edge technologies that have had a lasting impact on the healthcare sector.

Conclusion:

In conclusion, Alexander M Klibanov's passion for innovation and his dedication to improving healthcare have solidified his reputation as a pioneering inventor. His contributions continue to inspire the next generation of inventors and shape the future of the industry.

This text is generated by artificial intelligence and may not be accurate.